69 related articles for article (PubMed ID: 38542355)
21. Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
Harati R; Hafezi S; Mabondzo A; Tlili A
PLoS One; 2020; 15(10):e0239292. PubMed ID: 33002044
[TBL] [Abstract][Full Text] [Related]
22. Low-Temperature In-Induced Holes Formation in Native-SiO
R Reznik R; P Kotlyar K; O Gridchin V; V Ubyivovk E; V Federov V; I Khrebtov A; S Shevchuk D; E Cirlin G
Materials (Basel); 2020 Aug; 13(16):. PubMed ID: 32764363
[TBL] [Abstract][Full Text] [Related]
23. Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.
Izraely S; Witz IP
Int J Cancer; 2021 Mar; 148(6):1308-1322. PubMed ID: 32761606
[TBL] [Abstract][Full Text] [Related]
24. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway.
Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A
Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395
[TBL] [Abstract][Full Text] [Related]
25. Insights into the Mechanism of Action of Highly Diluted Biologics.
Tarasov SA; Gorbunov EA; Don ES; Emelyanova AG; Kovalchuk AL; Yanamala N; Schleker ASS; Klein-Seetharaman J; Groenestein R; Tafani JP; van der Meide P; Epstein OI
J Immunol; 2020 Sep; 205(5):1345-1354. PubMed ID: 32727888
[TBL] [Abstract][Full Text] [Related]
26. Loss of miR-101-3p Promotes Transmigration of Metastatic Breast Cancer Cells through the Brain Endothelium by Inducing COX-2/MMP1 Signaling.
Harati R; Mohammad MG; Tlili A; El-Awady RA; Hamoudi R
Pharmaceuticals (Basel); 2020 Jul; 13(7):. PubMed ID: 32645833
[TBL] [Abstract][Full Text] [Related]
27. Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells
Ittner C; Burek M; Störk S; Nagai M; Förster CY
Front Cardiovasc Med; 2020; 7():73. PubMed ID: 32432126
[TBL] [Abstract][Full Text] [Related]
28. Genes that Mediate Metastasis across the Blood-Brain Barrier.
Fares J; Kanojia D; Rashidi A; Ulasov I; Lesniak MS
Trends Cancer; 2020 Aug; 6(8):660-676. PubMed ID: 32417182
[TBL] [Abstract][Full Text] [Related]
29. Molecular and cellular mechanisms underlying brain metastasis of breast cancer.
Hosonaga M; Saya H; Arima Y
Cancer Metastasis Rev; 2020 Sep; 39(3):711-720. PubMed ID: 32399646
[TBL] [Abstract][Full Text] [Related]
30. GPR30 expression and function in breast cancer cells are induced through a cis‑acting element targeted by ETS factors.
Segura-Bautista D; Olivares A; Casas-González P; Bonilla E; Salazar Z; Pérez-Solis MA
Oncol Rep; 2020 May; 43(5):1669-1682. PubMed ID: 32323852
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer brain metastasis: molecular mechanisms and directions for treatment.
Pedrosa RMSM; Mustafa DA; Soffietti R; Kros JM
Neuro Oncol; 2018 Oct; 20(11):1439-1449. PubMed ID: 29566179
[TBL] [Abstract][Full Text] [Related]
32. The effects of 17β-estradiol on blood brain barrier integrity in the absence of the estrogen receptor alpha; an in-vitro model.
Kuruca SE; Karadenizli S; Akgun-Dar K; Kapucu A; Kaptan Z; Uzum G
Acta Histochem; 2017 Jul; 119(6):638-647. PubMed ID: 28803749
[TBL] [Abstract][Full Text] [Related]
33. Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon.
Tzanakakis G; Kavasi RM; Voudouri K; Berdiaki A; Spyridaki I; Tsatsakis A; Nikitovic D
Dev Dyn; 2018 Mar; 247(3):368-381. PubMed ID: 28758355
[TBL] [Abstract][Full Text] [Related]
34. Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control.
Haddad-Tóvolli R; Dragano NRV; Ramalho AFS; Velloso LA
Front Neurosci; 2017; 11():224. PubMed ID: 28484368
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptor β as a Pharmaceutical Target.
Warner M; Huang B; Gustafsson JA
Trends Pharmacol Sci; 2017 Jan; 38(1):92-99. PubMed ID: 27979317
[TBL] [Abstract][Full Text] [Related]
36. Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention.
Weidle UH; Birzele F; Kollmorgen G; Rüger R
Cancer Genomics Proteomics; 2016; 13(4):245-58. PubMed ID: 27365375
[TBL] [Abstract][Full Text] [Related]
37. Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.
Drolez A; Vandenhaute E; Julien S; Gosselet F; Burchell J; Cecchelli R; Delannoy P; Dehouck MP; Mysiorek C
PLoS One; 2016; 11(3):e0151155. PubMed ID: 26958843
[TBL] [Abstract][Full Text] [Related]
38. Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: Role of Rac and PI3K.
Molnár J; Fazakas C; Haskó J; Sipos O; Nagy K; Nyúl-Tóth Á; Farkas AE; Végh AG; Váró G; Galajda P; Krizbai IA; Wilhelm I
Cell Adh Migr; 2016 May; 10(3):269-81. PubMed ID: 26645485
[TBL] [Abstract][Full Text] [Related]
39. Quantification of Malignant Breast Cancer Cell MDA-MB-231 Transmigration Across Brain and Lung Microvascular Endothelium.
Fan J; Fu BM
Ann Biomed Eng; 2016 Jul; 44(7):2189-201. PubMed ID: 26603751
[TBL] [Abstract][Full Text] [Related]
40. Blood-brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate.
Shityakov S; Salvador E; Pastorin G; Förster C
Int J Nanomedicine; 2015; 10():1703-13. PubMed ID: 25784800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
